A Government for Big Tobacco and Bigger Families

The Department of Health and Human Services has been in the news recently due to several developments. One issue involves the regulation of mifepristone, a topic of concern for antiabortion activists. The FDA approved a generic version of the drug last year, and a safety report is expected to be issued in the fall. Further details about these developments are available from the source. The FDA's approach to certain issues has drawn attention, and the timing of some announcements may have political implications. More information can be found in the original article, which discusses the FDA's actions and their potential impact.